SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.55 |
| Enterprise Value ($M) | 15.31 |
| Book Value ($M) | 8.29 |
| Book Value / Share | 7.15 |
| Price / Book | 0.31 |
| NCAV ($M) | -21.86 |
| NCAV / Share | -18.86 |
| Price / NCAV | -0.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.27 |
| Return on Assets (ROA) | -1.23 |
| Return on Equity (ROE) | -3.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.08 |
| Current Ratio | 0.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.00 |
| Assets | 32.14 |
| Liabilities | 23.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.13 |
| Operating Income | -27.86 |
| Net Income | -34.45 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.76 |
| Cash from Investing | -5.00 |
| Cash from Financing | 22.50 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 206,669 | 680,323 | 30.38 | |
| 55,359 | 197,633 | 28.01 | |
| 94,718 | 258,530 | 36.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACHV – Achieve Life Sciences, Inc. | ACXP – Acurx Pharmaceuticals, Inc. |
| ADIL – Adial Pharmaceuticals, Inc. | ADVM – Adverum Biotechnologies, Inc. |
| AGEN – Agenus Inc. |
Financial data and stock pages provided by
Fintel.io